Companies: 10,795·Total market cap: $144.5T
Onconetix, Inc.

Onconetix, Inc.

ONCONASDAQHealthcare● Active
$1.00
$-0.01(-0.99%)
Market Cap$334029
P/E Ratio
52W High$382.5
52W Low$0.91

Onconetix, Inc. (ONCO) Revenue

Annual & quarterly revenue history · segment & region breakdown

ONCO · revenue · updated Jun 10, 2026

Core revenue metrics

Onconetix, Inc. trailing twelve-month (TTM) revenue is $0.00B, an increase of 0.00% year-over-year from — in FY.

TTM revenue
$0.00B
4-quarter sum · USD
YoY growth
+0.00%
vs FY
Price / sales
0.44×
mktCap ÷ TTM rev
Revenue per day
$0M
Est. TTM ÷ 365
Revenue / employee
$61K
12 employees
FY
FY
5Y CAGR
Fiscal year end
Dec 31
Currency
USD · GAAP
Filing
10-K / 10-Q
Source: FMP · Onconetix, Inc. SEC filings · GAAPUpdated: 2026-06-10

Revenue trend

· Annual
YoY revenue growth %
revenue trend · revenue chart · revenue by year · revenue history

Revenue history

Fiscal year endRevenueChangeGrowth
ONCO revenue by year · ONCO revenue history · ONCO annual revenue data

About Revenue & Reporting

Revenue (also called sales, net sales, or turnover) is the total income Onconetix, Inc. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.

Onconetix, Inc. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.

Data sourced from Onconetix, Inc.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.

Figures tie to SEC 10-K/10-Q and FMP income-statement endpoints where noted.

Frequently asked questions

ONCO revenue · 4 questions

ONCO's trailing twelve-month (TTM) revenue is $0.00B. That is an increase of 0.00% year-over-year from — in FY.

ONCO revenueONCO annual revenuewhat is ONCO revenueONCO TTM revenue

Source: FMP · Onconetix, Inc. SEC filings · GAAP · Onconetix, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 10, 2026